Reunion Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Health News.

Press releases published on September 11, 2026

41 minutes ago

Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs

Indeterminate GlobeNewswire

an hour ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

Indeterminate GlobeNewswire

an hour ago

Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand

Indeterminate GlobeNewswire

an hour ago

Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement

Indeterminate GlobeNewswire

an hour ago

MADD Canada’s Roadside Memorial Sign in Waterloo Honours Leanne Holland Brown Killed in Impaired Driving Crash

Indeterminate GlobeNewswire

an hour ago

Le panneau commémoratif routier de MADD Canada à Waterloo rend hommage à Leanne Holland Brown, tuée dans une collision causée par un chauffard aux capacités affaiblies

Indeterminate GlobeNewswire

an hour ago

GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026

Indeterminate GlobeNewswire

an hour ago

Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial

Indeterminate GlobeNewswire

an hour ago

Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)

Indeterminate GlobeNewswire

an hour ago

Tempest Therapeutics Announces Up to $7.5 Million Private Placement

Indeterminate GlobeNewswire

2 hours ago

Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

2 hours ago

Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA

Indeterminate GlobeNewswire

2 hours ago

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System

Indeterminate GlobeNewswire

2 hours ago

Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand

Indeterminate GlobeNewswire

3 hours ago

Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand

Indeterminate GlobeNewswire

3 hours ago

Mark Holland se joint à la Fondation pour la santé des hommes au Canada à titre de l’un de ses nouveaux membres du conseil d’administration

Indeterminate GlobeNewswire

3 hours ago

Mark Holland Joins Canadian Men’s Health Foundation As One Of Its Newest Board Members

Indeterminate GlobeNewswire

4 hours ago

Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress

Indeterminate GlobeNewswire

4 hours ago

MemoVolt Launch 2026: New Natural Dual-Action Brain and Memory Support Formula Read MemoVolt Brain Supplement Facts & Ingredients Highlights.

Indeterminate GlobeNewswire

6 hours ago

Resolution Therapeutics completes enrollment in Phase I/II EMERALD clinical trial evaluating RTX001 in end-stage liver disease

Indeterminate GlobeNewswire